Streetbeat News

Stock Prices

BIIB

RETA

Biogen has agreed to acquire Reata Pharmaceuticals, causing Reata's shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:24 pm

XPEV

Jefferies has upgraded XPeng's stock from Hold to Buy and increased its price target from $7.8 to $25.3, leading to a rise in XPeng shares.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:24 pm

CLS

RBC Capital has upgraded Celestica's stock from Sector Perform to Outperform and raised its price target from $14 to $22. This has resulted in Celestica shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:23 pm

ADI

AMD

INTC

KLAC

LSCC

MRVL

NVDA

NXPI

QCOM

Semiconductor and chip stocks are trading higher following strong quarterly results from Intel and KLA. Other companies in the sector such as ADI, AMD, LSCC, MRVL, NVDA, NXPI, QCOM may also be affected.

Portfolio Pulse from Bill Haddad

July 28, 2023 | 1:22 pm

XOM

Exxon Mobil Corp (XOM) has the potential to bring lithium to the market at lower costs, according to the company's CEO. This could present a win-win-win opportunity for the company, consumers, and the environment.

Portfolio Pulse from Charles Gross

July 28, 2023 | 1:19 pm

CNHI

CNH Industrial reported its Q2 financial results and reaffirmed its guidance, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:15 pm

FIXX

Homology Medicines Inc (NASDAQ:FIXX) announced initial data from its pheEDIT Phase 1 trial, showing positive results. However, due to the current financing environment and anticipated clinical development timelines, Homology will not be further developing its programs and will be reducing its workforce by 87%. The company has retained TD Cowen as its strategic financial advisor. These measures are expected to extend Homology's cash runway into 2026. As of March 31, 2023, Homology had approximately $150.0 million in cash, cash equivalents, and short-term investments. FIXX shares are up 23.40% at $1.16 during the premarket session on the last check Friday.

Portfolio Pulse from Vandana Singh

July 28, 2023 | 1:14 pm

DECK

Deckers Outdoor reported Q1 financial results and issued FY24 revenue outlook below estimates, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:13 pm

CL

Colgate-Palmolive Company (NYSE:CL) reported Q2 FY23 sales growth of 7.5% YoY to $4.82 billion, beating the consensus of $4.67 billion. Non-GAAP EPS of $0.77 beat the analyst consensus of $0.75. The company sees strong investment levels to continue in the back half of the year to deliver balanced organic sales growth. However, CL shares are trading lower by 1.58% at $75.89 in premarket.

Portfolio Pulse from Nabaparna Bhattacharya

July 28, 2023 | 1:13 pm

TTD

The Trade Desk's stock has been upgraded from Neutral to Buy by BTIG, with a new price target of $103. This has resulted in the shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

July 28, 2023 | 1:11 pm